enVVeno Medical Corporation Warrants
NVNOW
NVNOW was delisted on the 26th of May, 2023.
0 hedge funds and large institutions have $0 invested in enVVeno Medical Corporation Warrants in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $24 → $0 (-$24)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$24 |
NVNOW Hedge Fund Activity: Q2 2023 in Review
0 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q2 2023, worth a combined $0 — down 100% from $24 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NVNOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Newbridge Financial Services Group, exiting entirely with an estimated $24 sold.
- 0 institutional investors held enVVeno Medical Corporation Warrants (NVNOW) as of Q2 2023, down from 1 in Q1 2023.
- Funds reported $0 of enVVeno Medical Corporation Warrants stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new enVVeno Medical Corporation Warrants positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest enVVeno Medical Corporation Warrants seller in Q2 2023 was Newbridge Financial Services Group, an estimated $24 sold.
Based on aggregated 13F filings for Q2 2023.